White Paper

Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workface amid COVID-19 and beyond.

White Paper Summary

The COVID-19 pandemic forced us to examine the impact and mitigation of infectious disease risk in the workplace as never before. It changed the way in which many of us work at least temporarily; for others, more permanently as some organizations make the decision to adopt long-term strategies for their workforce based on lessons learned from the pandemic. And in some cases, as exampled by the unprecedented federal mandate beholding businesses to rigorous vaccination and testing requirements for their employees, it is forcing employers to take on an increasingly larger role in solutioning what has traditionally been a public health issue.

Applying learnings from COVID beyond the pandemic and looking to the future to protect the health of employees, as well as the downstream productivity and cost considerations for employers, is a smart strategy, given the science and statistics of infectious disease in today’s environment.

For more content like this from Healthesystems visit their RxInformer clinical journal website.

Healthesystems is a leading provider of Pharmacy Benefit Management (PBM) & Ancillary Benefits Management programs for the workers' compensation industry.

More from Risk & Insurance